AIML.CN stock opened market hours at C$0.035 on CNQ on 23 Mar 2026, unchanged from the previous close. Trading volume was 35,000 versus a 50-day average near 421,658, flagging thin liquidity. Investors in AI healthcare plays should weigh weak fundamentals and high price volatility before placing size in this name.
Price snapshot and trading data
AI/ML Innovations Inc. (AIML.CN) trades on the CNQ exchange in Canada at C$0.035. The intraday range was C$0.035–C$0.040 and the year high is C$0.120 with a year low of C$0.030. Market capitalization stands at C$5,889,240.00 with 168,264,000 shares outstanding. Low liquidity is visible: current volume 35,000 versus average volume 421,658, giving a relative volume of 0.017.
Business model and sector context
AI/ML Innovations Inc. operates digital health and wearable software for caregivers and clinicians. The company sits in Healthcare and the Medical – Healthcare Information Services industry on CNQ in Canada. Sector peers show larger scale and stronger margins, which raises competitive and commercialization risk for a small cap like AIML.CN. For third-party comparisons see a recent market comparison source.
AIML.CN stock: Financials and valuation
Recent trailing numbers show EPS -0.03 and PE -1.17, reflecting negative earnings. Price-to-sales is 35.00, and price-to-book is 4.58, both high for a microcap. Cash per share is C$0.005 and book value per share is C$0.0075. The current ratio is 2.09, and debt-to-equity is 0.11, indicating modest leverage but thin operating cash flow.
Technicals and trading signals for AIML.CN stock
Technical indicators show non-trending action: RSI 43.36 and ADX 16.78, which suggests range-bound trading. Bollinger Bands sit at C$0.030–C$0.040. Average price over 50 days is about C$0.037 and 200-day average is C$0.046. Low relative volume and an order book thinness increase potential for sharp moves on news.
Meyka AI rating and analyst view
Meyka AI rates AIML.CN with a score out of 100: 62.11 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Independent provider company rating dated 2026-03-19 assigns C- (Strong Sell), highlighting valuation and profitability weaknesses. Investors should treat both signals as data points, not advice.
Outlook and price targets with AIML.CN forecast
Meyka AI’s forecast model projects a yearly price near C$0.022, implying -37.89% versus the current C$0.035. Short-term technical resistance sits at C$0.040 and support at C$0.030. A conservative 12-month target for downside scenarios is C$0.020, while an upside case, contingent on better commercialization, could reach C$0.080. Forecasts are model-based projections and not guarantees. For a live quote and deeper metrics visit AIML.CN on Meyka.
Final Thoughts
AIML.CN stock trades at C$0.035 on CNQ with low liquidity and weak fundamentals. Key strengths include a patent-pending digital health focus and a current ratio of 2.09. Key weaknesses are negative EPS -0.03, high price-to-sales 35.00, long receivables, and a thin float that magnifies volatility. Meyka AI’s model projects a yearly price near C$0.022, implying -37.89% versus today. That projection supports a cautious stance: speculative traders may use tight sizing and stops, while longer-term investors should wait for clearer revenue traction or strategic partnerships. Forecasts are model-based projections and not guarantees. Meyka AI is an AI-powered market analysis platform that provides these data-driven signals for research purposes only.
FAQs
What is the current price of AIML.CN stock and its liquidity?
AIML.CN stock is trading at C$0.035 on CNQ. Daily volume was 35,000 versus an average of 421,658, indicating low liquidity. Expect wider spreads and potential slippage on orders.
What does Meyka AI forecast for AIML.CN stock?
Meyka AI’s forecast model projects a yearly price around C$0.022, which implies about -37.89% from the current C$0.035. Forecasts are model-based projections and not guarantees.
Is AIML.CN stock a buy based on fundamentals?
Fundamentally AIML.CN shows negative EPS -0.03, high price-to-sales 35.00, and modest cash per share C$0.005. Meyka AI gives a Hold grade; other providers rate it C- (Strong Sell). That points to caution, not a buy signal today.
What are the main risks for AIML.CN stock?
Major risks include thin liquidity, negative profitability, long receivables (575 days), a small market cap C$5,889,240.00, and competitive pressure in digital health. These raise execution and dilution risk for investors.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)